Progyny, Inc. (PGNY) stock

PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 21/303% below fair value

$36.58+0.08 (+0.22%)

Close on Nov 12, 2026Market cap $2.81BP/E 33.6Yield –

Progyny EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Progyny's EV/EBITDA was 22.0× on Nov 11, 2026, against 21.3× a year earlier. Over the last 5 years it ranged from 12.3× to 209.1×, with a median of 34.9×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	22.0×	+1.3
2025	Dec 31, 2025	20.7×	+1.8
2024	Dec 31, 2024	18.8×	−41.1
2023	Dec 29, 2023	60.0×	−68.8
2022	Dec 30, 2022	128.7×	+3.0
2021	Dec 31, 2021	125.7×	−219.9
2020	Dec 31, 2020	345.6×	+318.5
2019	Dec 31, 2019	27.1×	–